TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/11/2025
Back to search
Official data from USPTO
OZETTE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
08/12/2025
Trademark type
Word
Nice classes
42, 44
Filing date
04/21/2022
Registration date
05/21/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/21/2024
Last transaction
08/12/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2023-05-00
First use in commerce
2023-05-00
Drawing code
4
Owner type
03
Owner location
Seattle, WA
Examiner
AURAND, MEGAN
Law office
O10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Ozette Technologies, Inc.
Representatives
Chelsea E. Carbone WILSON SONSINI GOODRICH & ROSATI
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Providing temporary use of non-downloadable computer software using artificial intelligence (AI) and machine learning for analyzing immune data for the purposes of medical researchdiagnosistreatment; providing temporary use of non-downloadable computer software using artificial intelligence (AI) and machine learning for analyzing immune data for the purposes of identifyingprescribing and monitoring medications; providing temporary use of non-downloadable computer software using artificial intelligence (AI) and machine learning for diagnosingmonitoring and treating diseases and disordersinfectious diseasecancerautoimmune disorderscardiovascular diseaseneurological disorders; scientific research and development; pharmaceutical research and development; medical research; medical and pharmaceutical research services; cloud hosting provider services for storinganalyzing and sharing biological information; providing an online network environment service featuring technology that enables users to storeanalyze and share data in the fields of life science; technical support servicesinfrastructure management services for monitoringadministration and management of cloud computing IT and application systems in the fields of life science; product design and development of laboratory apparatus and instruments and design and development of computer software systems for use in analysis of biomolecules; installation and maintenance of computer software and software databases used in the field of analysis of biomolecules; consultancyinformationadvisory services in the field of medical research analysis of biomoleculesdiseasesdisorderstreatment efficacy; product developmentdeveloping equipment for use in preparingdetectingsequencingquantifyinganalyzing proteins and other biological moleculesautomated laboratory equipment and systemscomputer systems for collectingstoringanalyzingreporting biological informationfor sample tracking and managing projectslaboratory workflow and data to the order and specification of othersall the foregoing in the fields of scientific and clinical research; medical and scientific research in the fields of vaccinespharmaceuticalsbiologicsvaccinesadjuvantsadjuvant formulationsbiologic formulationsdrug deliverydiagnosticsmedical therapeutics; product research and development in the fields of pharmaceuticalsvaccinesdiagnosticsadjuvantsadjuvant formulationsbiologic formulationsdrug delivery; custom design and development of chemical reagents and biochemical assays; testing of pharmaceuticals; scientific laboratory services; computer and scientific research in the field of artificial intelligence (AI) and machine learning for analysis of immune datadisease statestreatment response
Class 44
Medical testing and reporting for diagnostic or treatment purposes; consultancyinformationadvisory services in the field of medical treatment of infectious diseasecancerautoimmune disorderscardiovascular diseaseneurological disorders
Publications
History of USPTO decisions and trademark events.
38 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/11/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/11/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/11/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/11/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/21/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
05/21/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/17/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/16/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/23/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/22/2024
DPCC
DIVISIONAL PROCESSING COMPLETE
03/22/2024
EX1G
SOU EXTENSION 1 GRANTED
03/22/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/29/2024
IUAF
USE AMENDMENT FILED
02/06/2024
DRRR
DIVISIONAL REQUEST RECEIVED
02/06/2024
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
02/06/2024
EISU
TEAS STATEMENT OF USE RECEIVED
02/06/2024
EXT1
SOU EXTENSION 1 FILED
02/05/2024
EEXT
SOU TEAS EXTENSION RECEIVED
02/05/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/22/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/27/2023
PUBO
PUBLISHED FOR OPPOSITION
06/27/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/07/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/25/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
05/25/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/25/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
05/25/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/25/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/24/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/22/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/22/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/23/2023
GNRT
NON-FINAL ACTION E-MAILED
02/23/2023
CNRT
NON-FINAL ACTION WRITTEN
02/23/2023
DOCK
ASSIGNED TO EXAMINER
02/08/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/27/2022
NWAP
NEW APPLICATION ENTERED
04/25/2022
Continuous trademark protection
Get notified about every new filing that threatens OZETTE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.